Marinus Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.27 | -100% | -4.84 | -100% |
| P/S |
|
18.11 | 33.44 | -45.85% |
|
|
| P/BV |
|
33.47 | 4.64 | 620.82% |
|
|
| P/FCF |
|
-4.22 | 42.53 | -109.92% |
|
|
| Ev/Ebitda |
|
-4.21 | -17.68 | -76.2% |
|
|
| Ev/S |
|
17.78 | 22.59 | -21.32% |
|
|
| Ev/FCF |
|
-4.66 | 47.55 | -109.81% |
|
|
| E/P |
|
-0.2837 | 0.0182 | -1658.79% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-422.52 | -14.2 | 2874.69% | -1085.75 | -61.09% |
| ROE |
|
-843.45 | 9.78 | -8721.89% |
|
|
| ROA |
|
-82.74 | 0.33 | -25168.26% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-456.31 | -26.41 | 1627.55% |
|
|
| ROCE |
|
-784.28 | 14.5 | -5508.17% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.5801 | -3.87 | -85.02% | -3.35 | -82.69% |
| Nеt Debt/Ebitda |
|
0.078 | -4.24 | -101.84% |
|
|
| Debt/Ratio |
|
0.4444 | 0.1853 | 139.86% |
|
|
| Debt/Equity |
|
18.09 | 1.56 | 1057.08% |
|
|
| Debt/Net Income |
|
-0.5372 | 10.06 | -105.34% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5351 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.235 | -100% |
|
|
| Average dividend growth |
|
0 | 1.41 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.486 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.64 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5351 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
30889 | 30.62 | 100778.51% | ||
| Growth impulse Ebitda in 5 years |
|
131.78 | -17.42 | -856.49% | ||
| Growth impulse Net Income in 5 years |
|
162.74 | -52.26 | -411.4% | ||
| Growth impulse FCF in 5 years |
|
140.96 | -31.68 | -544.95% | ||
| Growth impulse EPS in 5 years |
|
-33.38 | -61.82 | -46% |
IP Score
3.93/10
